Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.
about
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cellsTherapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver diseaseUltrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice.Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Neural stem cell therapy for cancer.The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbillivirusesTransgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in miceSelective elimination of long INterspersed element-1 expressing tumour cells by targeted expression of the HSV-TK suicide gene.Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide geneFolate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.Gene therapy for cancer treatment: past, present and futureProdrugs for improving tumor targetability and efficiency.Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors.Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapyAdenoviral-delivered HE4-HSV-tk sensitizes ovarian cancer cells to ganciclovirHighly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop.Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.Gene therapy of liver diseases.Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like ParticlesThe roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapyTherapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells.Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo.Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.Specifically targeted gene therapy for small-cell lung cancer.Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells.Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.Visualization and genetic manipulation of adult neurogenesis using transgenic mice.Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.The use of convection-enhanced delivery with liposomal toxins in neurooncology.Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
P2860
Q24796801-73C4F575-4DC3-4665-883F-2CD376ED635BQ28263579-AD9F7C9C-74CD-4C65-984C-BA9D615D4C09Q28472958-304C9495-69AB-4F41-AB7C-8C4565229522Q30477547-0B9A7A8A-65C6-4BFF-A9DA-E679DDE16175Q33604560-6F1BB48A-FCA9-4060-AD00-3E3ACFA2DBE2Q33704489-62EF9478-7FAC-475A-980F-A798184E2056Q33820699-5CF60BA9-FE3A-49A5-96D2-4044C593CA7CQ33842566-2C9D4819-D1E6-44DF-9F02-6B9CED3C71D8Q33888758-23443F74-9783-4472-9139-8DEA91E7C834Q34027421-B227FD5A-C672-43E6-8AFC-BB84E6452015Q34459264-4470BC5B-ABA0-4E56-9A0C-4B6F4CD52B78Q34459849-B3932E4B-B0DC-4546-B52C-D077FB0BFA21Q34557622-8D3F94F5-9849-465A-92ED-265A0666D8B5Q35040146-3C512692-0798-4379-86F0-D6D30019C11DQ35095165-CD3C4423-9103-4EC3-8597-7B4FB86FB608Q35176800-0D7F4B63-0E60-47CA-BF25-80ABD65E0419Q35198414-1BA38A2F-2947-4363-9A54-F7F6D05DB72DQ35549847-4F257989-B8F2-4459-8803-70ED07B4E130Q35553117-64769975-5869-4DB4-A13B-764F68383D22Q35634132-2A71DC80-72F3-4A0C-AE07-6B1ABE2A4A09Q35695549-907F4428-A038-4180-B572-352611227CFBQ35760658-AF7B31FF-AABC-4F24-804D-DF19BACCDCF4Q35842662-CBD90CF0-FE96-4932-90CB-5BC3B6529ED0Q36056773-5B538690-4706-4138-A75A-1413113E24A4Q36618550-F5577822-89D2-4D0B-9C13-6DF114D62881Q36640056-374B9113-7EC0-4C94-94A6-6CB2EB543DB2Q36825943-BA872453-C1A7-49A1-8CDC-AE9789F5CB4DQ37134623-D51F3D26-D6D4-4839-87EC-4B6049264763Q37158240-69FF59E0-FB5F-4618-A4CD-1A962467E297Q37222788-839DACC5-E7DF-4B7B-B612-A8030546E2BBQ37431500-62254D5B-A78A-477A-AFB9-57A824452FA8Q37449030-796C317D-06CF-4E9A-B43E-8A660E8A481DQ37576708-C917DB81-20DD-471F-B15A-6F7F16D5D882Q37653325-EF60DF1E-97C7-493E-8E9E-756C250A417AQ37662190-A71C74E7-63B4-4DA6-B1A5-A46CD4F64472Q37668555-A333EBB8-4804-4445-B49B-6B0FC10F6B14Q37852093-45178D2C-AE16-4631-AFA0-01C591C0A16CQ37948053-D107F0FD-9F1D-4BCD-A004-FB4FECED78EEQ37954331-3EA9B2C7-69DB-401D-9016-2876E9A67F47Q38058289-D972465B-A108-496A-A3D9-0EBD65ABB003
P2860
Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Suicide gene therapy mediated ...... fifteen years of application.
@ast
Suicide gene therapy mediated ...... fifteen years of application.
@en
type
label
Suicide gene therapy mediated ...... fifteen years of application.
@ast
Suicide gene therapy mediated ...... fifteen years of application.
@en
prefLabel
Suicide gene therapy mediated ...... fifteen years of application.
@ast
Suicide gene therapy mediated ...... fifteen years of application.
@en
P2093
P921
P356
P1433
P1476
Suicide gene therapy mediated ...... : fifteen years of application
@en
P2093
P356
10.2174/1566523033347426
P407
P50
P577
2003-02-01T00:00:00Z